For information about any of these trials, you may contact the individuals who are listed with each trial or study below, or you may contact us at our general USC MS Comprehensive Care Center number (323-442-6870) or email address (mscare@usc.edu).
Please note that appointments to see our doctors for non-research related care may be made by calling the Weiner Neurology Clinic at 323-442-5710.
Open Label Follow-Up Study Of Glatiramer Acetate (Copaxone) In Relapsing-Remitting MS
Status:
Closed for Enrollment. Study Ongoing.
Sponsors:
Teva Neurosciences
Type of Study and Brief Description:
We began this study in 1994 to monitor patients treated at our center with Copaxone for relapsing-remitting MS, as participants in a large, multicenter Phase II trial that ran from 1991-1994. Copaxone is a synthetic mixture of amino acids that is believed to control only those immune activities that cause damage to myelin, the material that insulates nerves. This continuation of the monitoring “phase” of this trial provides valuable information about the long term effects of Copaxone, indicated by measures of quality of life, neurologic health, and serial brain MRI scanning.
Background:
USC Principal Investigator:
Norm Kachuck, MD
Contact:
Pat Gutierrez (323-442-6870 or mstcell@usc.edu)
Additional Information:
You can click here for a document that describes more about this trial.
Back to top
|
